[1] SINGER M, DEUTSCHMAN CS, SEYMOUR CW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. [2] NAMGUNG M, AHN C, PARK Y, et al.Mortality among adult patients with sepsis and septic shock in Korea: a systematic review and meta-analysis[J]. Clin Exp Emerg Med, 2023, 10(2):157-171. [3] NEDEVA C, MENASSA J, DUAN M, et al.TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis[J]. Nat Immunol, 2020, 21(12): 1585-1596. [4] 张爱华,赖伟华,王敏,等. 双歧杆菌三联活菌胶囊联合肠内营养在脓毒症机械通气患者呼吸机相关性肺炎预防中的效果研究[J/CD]. 新发传染病电子杂志,2023,8(3):29-33. [5] 吴森泉,方年新,莫伟良,等.山柰酚抑制NLRP3炎症小体活化和细胞焦亡提高脓毒症小鼠生存率[J/CD].新发传染病电子杂志,2022, 7(1):12-16. [6] LIU Y, WANG K, FENG Q, et al.Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model[J]. J Immunol Res, 2021, 2021: 9998517. [7] UMAKOSHI K, CHOUDHURY ME, NISHIOKA R, et al.B lymphocytopenia and Bregs in a not-to-die murine sepsis model[J]. Biochem Biophys Res Commun, 2020, 523(1): 202-207. [8] XIE J, WANG H, KANG Y, et al.The Epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional Survey[J]. Crit Care Med, 2020, 48(3): e209-e218. [9] DEMARET J, VENET F, FRIGGERI A, et al.Marked alterations of neutrophil functions during sepsis-induced immunosuppression[J]. J Leukoc Biol, 2015, 98(6): 1081-1090. [10] KAUFMANN I, HOELZL A, SCHLIEPHAKE F, et al.Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity[J]. Shock, 2006, 26(3): 254-261. [11] YANG J, ZHU X, FENG J.The Changes in the Quantity of Lymphocyte Subpopulations during the Process of Sepsis[J]. Int J Mol Sci, 2024, 25(3):1902-1914. [12] DAVIES K, MCLAREN JE.Destabilisation of T cell-dependent humoral immunity in sepsis[J]. Clin Sci (Lond), 2024, 138(1):65-85. [13] FINFER S, VENKATESH B, HOTCHKISS RS, et al.Lymphopenia in sepsis-an acquired immunodeficiency?[J]. Immunol Cell Biol, 2023, 101(6):535-544. [14] HUANG Z, FU Z, HUANG W, et al.Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis[J]. Am J Emerg Med, 2020, 38(3): 641-647. [15] LORENTE L, MARTIN MM, ORTIZ-LOPEZ R, et al.Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality[J]. Enferm Infecc Microbiol Clin (Engl Ed), 2022, 40(5): 235-240. [16] SARI R, KARAKURT Z, AY M, et al.Neutrophil to lymphocyte ratio as a predictor of treatment response and mortality in septic shock patients in the intensive care unit[J]. Turk J Med Sci, 2019, 49(5): 1336-1349. [17] LIU Y, ZHENG J, ZHANG D, et al.Neutrophil-lymphocyte ratio and plasma lactate predict 28-day mortality in patients with sepsis[J]. J Clin Lab Anal, 2019, 33(7): e22942. [18] RYOO SM, HAN KS, AHN S, et al.The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: A multicenter prospective registry-based observational study[J]. Sci Rep, 2019, 9(1): 6579. [19] ZHANG H, WANG X, ZHANG Q, et al.Comparison of procalcitonin and high-sensitivity C-reactive protein for the diagnosis of sepsis and septic shock in the oldest old patients[J]. BMC Geriatr, 2017, 17(1): 173. [20] CUI N, ZHANG H, CHEN Z, et al.Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases[J]. J Int Med Res, 2019, 47(4): 1573-1579. [21] ASSICOT M, GENDREL D, CARSIN H, et al.High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(8844): 515-518. [22] JEKARL DW, LEE S, KIM M, et al.Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3[J]. J Clin Lab Anal, 2019, 33(9): e22996. |